Project Details
Description
A Phase 3, Multicenter, Randomized, Open-label, Active-controlled StudytoAssesstheEfficacyandSafetofMaribavirTreatmentComparedtoInvestigatorassignedTreatmentinTransplantRecw/Cytomegalovirus (CMV)InfectionsthatareRefractoryorResistanttoTreatmentwithGanci
| Status | Finished |
|---|---|
| Effective start/end date | 1/1/17 → 4/30/21 |
Funding
- SHIRE HUMAN GENETIC THERAPIES, INC.
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.